Eukles Asset Management »

Humacyte shares owned by Eukles Asset Management

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by Eukles Asset Management from 13F filings

Historical chart of Eukles Asset Management investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by Eukles Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by Eukles Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.4k 1.0k 5.44
2024-06-30 $4.8k 1.0k 4.80

More positions owned by Eukles Asset Management

NVIDIA Corporation Common Stock (NVDA)
Microsoft Corporation Common Stock (MSFT)
Apple Common Stock (AAPL)
iShares Russell 1000 Growth ETF MF Closed and MF Open (IWF)
Mastercard Incorporated Class A Common Stock (MA)
United Rentals Common Stock (URI)
Cboe Global Markets Common Stock (CBOE)
Accenture Plc Class A Common Stock (ACN)
Novo Nordisk A/S Sponsored ADR Class B Common Stock (NVO)
Caterpillar Common Stock (CAT)
ResMed Common Stock (RMD)
TJX Companies Common Stock (TJX)
Sherwin-Williams Company Common Stock (SHW)
CBRE Group, Inc. Class A Common Stock (CBRE)
Progressive Corporation Common Stock (PGR)

View all positions for Eukles Asset Management

Top funds holding Humacyte

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Voloridge Investment Management
Nuveen Asset Management
Two Sigma Investments
Susquehanna International
Woodline Partners
Northern Trust
Goldman Sachs Group
Charles Schwab Investment Management
Marshall Wace
Monashee Investment Management

View all funds holding Humacyte